Security key
221015100
Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS)
CUSIP: 221015100
Q1 2020 13F Holders as of 31 Mar 2020
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 91,091,040
- Total 13F shares
- 20,651,240
- Share change
- -126,461
- Total reported value
- $43,573,167
- Price per share
- $2.11
- Number of holders
- 36
- Value change
- -$3,308,904
- Number of buys
- 18
- Number of sells
- 14
Report period
Q1 2020
Institutions
36
Top holders
10
CRVS full security history
Newer quarter: Q2 2020
Previous quarter: Q4 2019
Corvus Pharmaceuticals, Inc. SEC filings
Corvus Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 221015100
Recent filing periods:
Top shareholders of CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
7.4%
|
6,767,584
|
$36,816,000 | — | 31 Dec 2019 | |
| ADAMS STREET PARTNERS LLC |
13F
|
Company |
3.6%
|
3,275,616
|
$17,819,000 | — | 31 Dec 2019 | |
| Novo Holdings A/S |
13F
|
Company |
3.2%
|
2,927,560
|
$15,926,000 | — | 31 Dec 2019 | |
| BVF INC/IL |
13F
|
Company |
1.8%
|
1,627,568
|
$8,854,000 | — | 31 Dec 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.99%
|
906,200
|
$4,930,000 | — | 31 Dec 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.88%
|
799,830
|
$4,351,000 | — | 31 Dec 2019 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.81%
|
737,612
|
$4,013,000 | — | 31 Dec 2019 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.71%
|
647,174
|
$3,521,000 | — | 31 Dec 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.63%
|
574,227
|
$3,124,000 | — | 31 Dec 2019 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.5%
|
454,671
|
$2,472,000 | — | 31 Dec 2019 | |
| CHI Advisors LLC |
13F
|
Company |
0.41%
|
370,307
|
$2,014,000 | — | 31 Dec 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.34%
|
313,837
|
$1,707,000 | — | 31 Dec 2019 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.18%
|
159,773
|
$869,000 | — | 31 Dec 2019 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.16%
|
150,000
|
$816,000 | — | 31 Dec 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
137,555
|
$748,000 | — | 31 Dec 2019 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
133,700
|
$727,000 | — | 31 Dec 2019 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.12%
|
108,599
|
$591,000 | — | 31 Dec 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.12%
|
107,176
|
$583,000 | — | 31 Dec 2019 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.09%
|
81,800
|
$445,000 | — | 31 Dec 2019 | |
| Hikari Power Ltd |
13F
|
Company |
0.09%
|
80,000
|
$435,000 | — | 31 Dec 2019 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.09%
|
79,233
|
$431,000 | — | 31 Dec 2019 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.08%
|
75,996
|
$413,000 | — | 31 Dec 2019 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.07%
|
67,906
|
$369,000 | — | 31 Dec 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
38,628
|
$210,000 | — | 31 Dec 2019 | |
| Puissance Capital Management LP |
13F
|
Company |
0.04%
|
38,010
|
$207,000 | — | 31 Dec 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
26,852
|
$146,000 | — | 31 Dec 2019 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.03%
|
22,861
|
$124,000 | — | 31 Dec 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
22,811
|
$124,000 | — | 31 Dec 2019 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.02%
|
16,580
|
$90,000 | — | 31 Dec 2019 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.01%
|
13,583
|
$74,000 | — | 31 Dec 2019 | |
| RAYMOND JAMES TRUST N.A. |
13F
|
Company |
0.01%
|
13,158
|
$72,000 | — | 31 Dec 2019 | |
| MEEDER ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
2,088
|
$11,000 | — | 31 Dec 2019 | |
| Advisor Group, Inc. |
13F
|
Company |
0%
|
1,000
|
$5,000 | — | 31 Dec 2019 | |
| Manchester Capital Management LLC |
13F
|
Company |
0%
|
215
|
$1,000 | — | 31 Dec 2019 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
79
|
$430 | — | 31 Dec 2019 |
Institutional Holders of Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) as of Q1 2020
As of 31 Mar 2020,
Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,651,240 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, ADAMS STREET PARTNERS LLC, Novo Holdings A/S, BVF INC/IL, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, EcoR1 Capital, LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, and CHI Advisors LLC.
This page lists
36
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2020 vs Q4 2019 Across Filers
Q4 2019 holders
35
Q1 2020 holders
36
Holder diff
1
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 Value $ | Q1 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.